Elanco Animal Valuation
| ELAN Stock | USD 24.75 0.67 2.78% |
At this time, the firm appears to be overvalued. Elanco Animal Health shows a prevailing Real Value of $23.71 per share. The current price of the firm is $24.75. Our model computes the value of Elanco Animal Health from reviewing the firm fundamentals such as Profit Margin of 0.01 %, current valuation of 15.82 B, and Operating Margin of 0.02 % as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 1.7927 | Enterprise Value | Enterprise Value Ebitda 18.5924 | Price Sales 2.6353 | Forward PE 23.2019 |
Overvalued
Today
Please note that Elanco Animal's price fluctuation is very steady at this time. Calculation of the real value of Elanco Animal Health is based on 3 months time horizon. Increasing Elanco Animal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Elanco Animal is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elanco Stock. However, Elanco Animal's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.75 | Real 23.71 | Target 25.92 | Hype 24.75 | Naive 23.96 |
The intrinsic value of Elanco Animal's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elanco Animal's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Elanco Animal Health helps investors to forecast how Elanco stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elanco Animal more accurately as focusing exclusively on Elanco Animal's fundamentals will not take into account other important factors: Elanco Animal Cash |
|
Elanco Animal Total Value Analysis
Elanco Animal Health is currently forecasted to have valuation of 15.82 B with market capitalization of 12.1 B, debt of 4.32 B, and cash on hands of 463 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Elanco Animal fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.82 B | 12.1 B | 4.32 B | 463 M |
Elanco Animal Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elanco Animal Health has Price/Earnings (P/E) ratio of 241.75. The entity had not issued any dividends in recent years. Elanco Animal Health is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in March.Elanco Animal Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elanco Animal has an asset utilization ratio of 35.19 percent. This suggests that the Company is making $0.35 for each dollar of assets. An increasing asset utilization means that Elanco Animal Health is more efficient with each dollar of assets it utilizes for everyday operations.Elanco Animal Profitability Analysis
Taking into consideration Elanco Animal's profitability measurements, Elanco Animal Health is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in March. Profitability indicators assess Elanco Animal's ability to earn profits and add value for shareholders.Net Income | First Reported 2016-12-31 | Previous Quarter 11 M | Current Value -34 M | Quarterly Volatility 207.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.34 | 0.39 |
|
|
For Elanco Animal profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elanco Animal Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elanco Animal utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elanco Animal's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elanco Animal over time as well as its relative position and ranking within its peers.
Elanco Animal Earnings per Share Projection vs Actual
By analyzing Elanco Animal's earnings estimates, investors can diagnose different trends across Elanco Animal's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Elanco Animal Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Elanco Animal Ownership Allocation
The majority of Elanco Animal Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elanco Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elanco Animal. Please pay attention to any change in the institutional holdings of Elanco Animal Health as this could imply that something significant has changed or is about to change at the company. On November 14, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Elanco Animal Health's common stock.Elanco Animal Profitability Analysis
The company reported the previous year's revenue of 4.44 B. Net Income was 338 M with profit before overhead, payroll, taxes, and interest of 2.52 B.About Elanco Animal Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Elanco Animal Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Elanco Animal Health based exclusively on its fundamental and basic technical indicators. By analyzing Elanco Animal's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Elanco Animal's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Elanco Animal. We calculate exposure to Elanco Animal's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elanco Animal's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.2 B | 1.7 B | |
| Pretax Profit Margin | 0.11 | 0.13 | |
| Operating Profit Margin | 0.05 | 0.05 | |
| Net Profit Margin | 0.09 | 0.09 | |
| Gross Profit Margin | 0.39 | 0.34 |
Elanco Animal Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 497.3 M | |
| Quarterly Earnings Growth Y O Y | 1.167 | |
| Forward Price Earnings | 23.2019 |
Elanco Animal Current Valuation Indicators
Elanco Animal's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Elanco Animal's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Elanco Animal, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Elanco Animal's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Elanco Animal's worth.When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.167 | Earnings Share 0.07 | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.